US Edition
RFK Jr cancels $500m in mRNA vaccine development in the US
UNITED STATES, AUG 7 – Health Secretary Robert F. Kennedy Jr. halted 22 mRNA vaccine projects worth nearly $500 million, shifting focus to broader vaccine platforms amid concerns about mRNA efficacy against respiratory viruses.
- The U.S. Department of Health and Human Services announced a wind-down of mRNA vaccine development, impacting 22 projects valued at nearly $500 million, as per their press release.
- HHS Secretary Robert F. Kennedy Jr. stated that data indicates mRNA vaccines do not effectively protect against upper respiratory infections.
- Kennedy emphasized a shift towards safer vaccine strategies, like whole-virus vaccines, citing the shortcomings of mRNA technology.
- Some existing contracts will continue to protect taxpayer investments, but no new mRNA-based projects will be initiated, as emphasized by HHS's announcement.
359 Articles
359 Articles
RFK Jr is wrong about mRNA vaccines – a scientist explains how they make COVID less deadly
Joshua Sukoff/ShutterstockUS health secretary Robert F. Kennedy Jr has announced he is cancelling US$500 million (£374 million) of research into mRNA vaccines, citing unproven concerns about their safety and long-term effects. Kennedy has claimed that mRNA vaccines “encourage new mutations and can actually prolong pandemics” – a misleading statement that contradicts the scientific consensus on viral evolution and effects of vaccination. But scie…
Doctors say ‘deeply troubling’ RFK Jr cuts to mRNA vaccine grants put the US at risk
‘A tremendous step backward, the politicization of science, and RFK Jr., who has been a lifelong anti-vaccine propagandist and science denialist, is now making policy,’ one doctor said
Former Trump official calls Kennedy's latest move a 'huge strategic misstep' that 'deeply compromises national security'
Health Secretary Robert F. Kennedy Jr. announced Tuesday his plans to cancel $500 million in vaccine development projects, marking a significant shift in federal health policy. The decision targets all projects that utilize mRNA technology, the same platform used in COVID-19 vaccines from Pfizer and Moderna. Kennedy, who has long been critical of vaccines, stated that the move follows a comprehensive review of scientific evidence. According to P…
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
